Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
Prostate Cancer
About this trial
This is an interventional prevention trial for Prostate Cancer focused on measuring adenocarcinoma of the prostate, stage I prostate cancer, stage IIB prostate cancer, stage IIA prostate cancer, stage III prostate cancer, stage IV prostate cancer
Eligibility Criteria
DISEASE CHARACTERISTICS: Diagnosis of adenocarcinoma of the prostate Previously untreated and on watchful waiting Medically able to receive dietary intervention PATIENT CHARACTERISTICS: Age: 40 to 80 Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: Must be willing to travel to UCLA 3 days a week for 4 weeks to obtain specially prepared foods PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: Not specified Endocrine therapy: No concurrent luteinizing hormone-releasing hormone agonists (leuprolide or goserelin) No concurrent androgen-receptor blocking agents (flutamide or bicalutamide) No concurrent testosterone No concurrent insulin No concurrent finasteride Radiotherapy: Not specified Surgery: No prior orchiectomy Other: No concurrent saw palmetto supplement
Sites / Locations
- Jonsson Comprehensive Cancer Center, UCLA